Price $6.77 |
Market Cap
51.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.75
|
P/S
0.46
|
Dividend %
-
|
|
P/CF
9.4
|
P/FCF
-
|
Op. Cash Flow
4.1K
|
FCF
0.0
|
|
Op. Margin
-3.80%
|
Net Margin
-3.20%
|
ROE
-4.80%
|
ROI
6.00%
|
|
ROA
-3.30%
|
EPS Growth
-139.10%
|
Current Ratio
5.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| American Bio Medica Corporatio (ABMC) | $0.19 | - | - | 10M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $2.86 | - | - | 70.1M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $3.85 | - | - | 1.23B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $8.82 | - | - | 10.43B | Strong Buy |
| Dynasil Corporation of America (DYSL) | $0.90 | - | - | 13.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
